Financhill
Sell
38

EVAX Quote, Financials, Valuation and Earnings

Last price:
$2.65
Seasonality move :
-0.17%
Day range:
$2.75 - $2.93
52-week range:
$1.20 - $17.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.83x
P/B ratio:
1.69x
Volume:
78.4K
Avg. volume:
110K
1-year change:
-83.66%
Market cap:
$17.5M
Revenue:
$3.3M
EPS (TTM):
-$12.00

Analysts' Opinion

  • Consensus Rating
    Evaxion AS has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $13.25, Evaxion AS has an estimated upside of 378.34% from its current price of $2.77.
  • Price Target Downside
    According to analysts, the lowest downside price target is $6.00 representing 100% downside risk from its current price of $2.77.

Fair Value

  • According to the consensus of 1 analyst, Evaxion AS has 378.34% upside to fair value with a price target of $13.25 per share.

EVAX vs. S&P 500

  • Over the past 5 trading days, Evaxion AS has underperformed the S&P 500 by -11.16% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Evaxion AS does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Evaxion AS has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Evaxion AS reported revenues of $3M.

Earnings Growth

  • Evaxion AS has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Evaxion AS reported earnings per share of -$0.50.
Enterprise value:
-346K
EV / Invested capital:
--
Price / LTM sales:
1.83x
EV / EBIT:
--
EV / Revenue:
-0.10x
PEG ratio (5yr expected):
--
EV / Free cash flow:
0.01x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-69.51%
Net Income Margin (TTM):
-347.86%
Return On Equity:
--
Return On Invested Capital:
-238.97%
Operating Margin:
-57.38%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Income Statement
Revenue -- -- -- $51K --
Gross Profit -- -- -- -- --
Operating Income -$25.2M -$20.2M -$14.2M -$4.4M -$3.9M
EBITDA -$23.4M -$14.7M -$14.8M $1.2M -$1.4M
Diluted EPS -$48.50 -$27.00 -$12.00 $1.50 -$0.50
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Balance Sheet
Current Assets $32.5M $35.4M $10.2M $11.7M $17.8M
Total Assets $34.9M $41.1M $20.5M $22.7M $25.2M
Current Liabilities $6M $4.7M -- -- --
Total Liabilities $7.1M $14.7M $13.9M $22.7M $25.2M
Total Equity $27.8M $26.4M $6.6M -- --
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2020-06-30 2021-06-30 2022-06-30 2021-06-30 2022-06-30
Cash Flow Statement
Cash Flow Operations -- -$18.7M -$23.8M -$7.5M -$5.2M
Cash From Investing -- -$1.1M -$744K -$495K -$77K
Cash From Financing -- $34.1M $32M -$35K -$300K
Free Cash Flow -- -$19.8M -$24.6M -$8M -$5.3M
EVAX
Sector
Market Cap
$17.5M
$32.3M
Price % of 52-Week High
15.61%
46.89%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.66%
1-Year Price Total Return
-83.66%
-37.62%
Beta (5-Year)
--
0.632
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $2.89
200-day SMA
Sell
Level $6.33
Bollinger Bands (100)
Buy
Level 1.34 - 2.96
Chaikin Money Flow
Sell
Level -58.9M
20-day SMA
Buy
Level $2.45
Relative Strength Index (RSI14)
Buy
Level 60.70
ADX Line
Buy
Level 39.98
Williams %R
Neutral
Level -34.0439
50-day SMA
Buy
Level $1.87
MACD (12, 26)
Buy
Level 0.33
25-day Aroon Oscillator
Buy
Level 80
On Balance Volume
Neutral
Level 115.6M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-15.0971)
Sell
CA Score (Annual)
Level (-7.5054)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (9.7293)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (0)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Evaxion AS is in the field of oncology. It used the AI-Immunology platform.

Stock Forecast FAQ

In the current month, EVAX has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The EVAX average analyst price target in the past 3 months is $13.25.

  • Where Will Evaxion AS Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Evaxion AS share price will rise to $13.25 per share over the next 12 months.

  • What Do Analysts Say About Evaxion AS?

    Analysts are divided on their view about Evaxion AS share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Evaxion AS is a Sell and believe this share price will drop from its current level to $6.00.

  • What Is Evaxion AS's Price Target?

    The price target for Evaxion AS over the next 1-year time period is forecast to be $13.25 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is EVAX A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Evaxion AS is a Buy. 1 of 1 analysts rates the stock a Buy at this time.

  • How Can I Buy Shares Of EVAX?

    You can purchase shares of Evaxion AS via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Evaxion AS shares.

  • What Is The Evaxion AS Share Price Today?

    Evaxion AS was last trading at $2.65 per share. This represents the most recent stock quote for Evaxion AS. Yesterday, Evaxion AS closed at $2.77 per share.

  • How To Buy Evaxion AS Stock Online?

    In order to purchase Evaxion AS stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will AST SpaceMobile Be In 5 Years?
Where Will AST SpaceMobile Be In 5 Years?

Ever tried to send a text from the Nevada desert…

Is TTD The Big Winner If Pharma Ads Are Banned?
Is TTD The Big Winner If Pharma Ads Are Banned?

Last week, Senators Bernie Sanders and Angus King introduced a…

Is Palantir Stock Overvalued?
Is Palantir Stock Overvalued?

By every traditional yardstick, including a price‑to‑sales well above 100,…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 48x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Sell
11
VEON alert for Jun 16

VEON [VEON] is up 2.47% over the past day.

Buy
74
DAVE alert for Jun 16

Dave [DAVE] is up 3.1% over the past day.

Buy
54
DAR alert for Jun 16

Darling Ingredients [DAR] is up 7.41% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock